The FDA announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications.
Read more: New FDA Draft Guidance Aims to Increase Safety Information About Dietary Supplement Marketplace